II. Epidemiology
-
Prevalence
- Meconium-stained amniotic fluid is present in up to 15% of deliveries
- Meconium Aspiration Syndrome occurs in only 1% of all deliveries
-
Gestational Age
- Meconium is only formed by the fetal Gastrointestinal Tract after 34 weeks
III. Pathophysiology
- Meconium Aspiration most often occurs in utero prior to delivery
- Meconium contains gastrointestinal fluids which cause localized inflammation
- Meconium Aspiration results
- Severe airway inflammation
- Airway obstruction
- Inactivation of surfactant (and decreased surfactant production)
- Pneumonia risk
IV. Risk Factors
- Advanced Gestational Age
- Thick meconium
- Emergency cesarean delivery
- APGAR <7
- Nonreassuring Fetal Heart Rate
V. Signs
VI. Differential Diagnosis
VII. Diagnosis: Criteria
- Meconium-stained amniotic fluid
- Respiratory Distress in the Newborn AND
- Supplemental Oxygen required in the first 2 hours of life to maintain O2Sat >92% AND
- Persists >12 hours AND
- No other alternative cardiopulmonary disorders identified
VIII. Imaging: Chest XRay
- Patchy infiltrates (fluffy densities) and Atelectasis
- Hyperinflation
- Lung Consolidation changes
IX. Management: Meconium stained infant
- See Respiratory Distress in the Newborn
- See Newborn Resuscitation
- Initial infant Resuscitation is the same for infants without meconium staining
- Oxygenation and ventilation
- Supplemental Oxygen 21-50% FIO2 to keep Oxygen Saturation >90%
- Non-Invasive Positive Pressure Ventilation (e.g. N-CPAP)
- Endotracheal Intubation may be required
- ECMO may be used in severe cases
-
Surfactant
- May improve oxygenation
- May decrease the risk of persistent Pulmonary Hypertension and other complications
X. Prevention
- Suctioning head at the perineum and endotracheal suctioning are no longer recommended
- See pathophysiology above regarding in utero aspiration
- Risk of airway injury complications outweigh any potential benefit
- Vain (2004) Lancet 364:597-602 [PubMed]
- Amnioinfusion does not decrease Meconium Aspiration risk
XI. Complications
- Persistent Pulmonary Hypertension
- Pneumonia risk
- Bronchial hyperactivity
- Asthma
- Developmental Delay